Development of dissolution method and comparative study of pharmaceutical solid forms containing cetirizine;Desenvolvimento de método de dissolução e estudo comparativo de formas farmacêuticas sólidas contendo cetirizina

Latin American Journal of Pharmacy

Volumn 26, Issue 1, 2007, Pages 108-114

  Cardoso, Simone Gonçalves ^a   Bajerski, Lisiane ^a   Malesuik, Marcelo Donadel ^a   Dorfey, Bianca ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

Cetirizine; Dissolution; Evaluation biopharmaceutical; Quality control

Indexed keywords

CETIRIZINE; HYDROCHLORIC ACID;

ARTICLE; COMPARATIVE STUDY; DISSOLUTION; DRUG DETERMINATION; DRUG FORMULATION; DRUG MANUFACTURE; DRUG QUALITY; DRUG SOLUBILITY; DRUG STRUCTURE; PHYSICAL CHEMISTRY; TABLET HARDNESS;

EID: 34447580165     PISSN: 03262383     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Simons, F.E.R (2002) Am. J. Med. 113: 38S-46S.
2. Gonzales, M.A., & K.S. Estes (1998) Int. J. Clin. Pharm. Ther. 36: 292-300.
3. British Pharmacopoeia (2003) London, Her Majesty's Stationary Office.
4. Pharmacopeial Forum (2006) 32: 1015.
5. Marcolongo, R. (2003) Dissertação (Mestrado em Fármacos e Medicamentos) - Universidade de São Paulo, São Paulo.
6. Manadas, R., M.E Pina & F.A. Veiga (2002) Rev. Bras. Cien. Farm. 38: 375-99.
7. Brasil (2004) ANVISA, RE no 310. Guia para realização do estudo e elaboração do relatório de equivalência farmacêutica e perfil de dissolução, Brasília.
8. Adams, E., D. Coomans, J. Smeyers-Verbeke & D.L Massart (2001) Int. J. Pharm. 226: 107-25.
9. Moore, J. W. & H.H. Flanner (1996) Pharm. Technol. 20: 64-74.
10. FDA (1997) "Guidance for Industry Dissolution Testing of Intermediate Release Solid Oral Dosage Forms", US Department of Health and Human Services (CDER).
11. Marques, M.R.C & W. Brown (2002) Ver. Analytica 1: 48-51.
12. Qureshi, S.A; MCGilvekay, I.J (1998) Eur. J. Pharm. Sci. 7: 249-58.
13. Siewert, M., L. Weinandy, D. Whiteman & C. Judkins (2002) Eur. J. Pharm.Biopharm. 53: 9-14.
14. Likar, M.D., H.L. Mansour & J.W. Harwood (2005) J. Pharm. Biom. Anal. 15: 543-51.
15. Bajerski, L., S.G. Cardoso, M.D Malesuik, I.F. Diefenbach & S.H Miollo (2005) J. AOAC Intern. 88: 424-7.
16. a ed. (1988) São Paulo: Atheneu.
17. Khan, K.A. & C.T. Rhodes (1975) J. Pharm. Pharmacol. 28: 48-9.
18. Rama, A.C.R., F. Veiga, I.V. Fieuiredo, A. Sousa & M. Cramona (2006) Ver. Bras. Cien. Farm. 42: 59-68.
19. Ansari, M., M. Kazemipour & J. Talebnia (2004) Diss. Technol. 8: 16-24
20. Brasil (2003) ANVISA, RE no 901. Guia para ensaios de dissolução para formas farmacêuticas sólidas orais de liberação imediata, Brasília.
21. The United States Pharmacopoeia (2004) 28 ed. Rockville, United States Convention.
22. ICH (1996) Steering Committee, Validation of Analytical Procedures: Methodology.